Literature DB >> 908492

Metabolism of ursodeoxycholic acid in man.

T Fedorowski, G Salen, A Calallilo, G S Tint, E H Mosbach, J C Hall.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 908492

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  22 in total

Review 1.  Ursodeoxycholic acid in the treatment of liver diseases.

Authors:  S Saksena; R K Tandon
Journal:  Postgrad Med J       Date:  1997-02       Impact factor: 2.401

2.  Ursodeoxycholic Acid Suppresses Lipogenesis in Mouse Liver: Possible Role of the Decrease in β-Muricholic Acid, a Farnesoid X Receptor Antagonist.

Authors:  Kyosuke Fujita; Yusuke Iguchi; Mizuho Une; Shiro Watanabe
Journal:  Lipids       Date:  2017-03-17       Impact factor: 1.880

3.  Hepatic biliary lipid secretion and gall bladder biliary lipid mass in gall stone patients: effect of ursodeoxycholic acid.

Authors:  A Lanzini; T C Northfield
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

Review 4.  Some pharmacokinetic considerations about homeostatic equilibrium of endogenous substances.

Authors:  A Marzo; A Rescigno; E Arrigoni Martelli
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1993 Apr-Jun       Impact factor: 2.441

Review 5.  Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. Part II.

Authors:  W H Bachrach; A F Hofmann
Journal:  Dig Dis Sci       Date:  1982-09       Impact factor: 3.199

6.  Oral cholelitholysis--cheno versus urso: Japanese experience.

Authors:  F Nakayama
Journal:  Dig Dis Sci       Date:  1980-02       Impact factor: 3.199

7.  Formation of hyodeoxycholic acid from muricholic acid and hyocholic acid by an unidentified gram-positive rod termed HDCA-1 isolated from rat intestinal microflora.

Authors:  H J Eyssen; G De Pauw; J Van Eldere
Journal:  Appl Environ Microbiol       Date:  1999-07       Impact factor: 4.792

8.  Faecal bile acid loss and bile acid pool size during short-term treatment with ursodeoxycholic and chenodeoxycholic acid in patients with radiolucent gallstones.

Authors:  G Salvioli; R Salati
Journal:  Gut       Date:  1979-08       Impact factor: 23.059

9.  Serum bile acids and oral ursodeoxycholic acid tolerance test in the diagnosis of esophageal varices.

Authors:  M Kadohara; H Kawasaki; C Hirayama
Journal:  Gastroenterol Jpn       Date:  1987-10

10.  Bile acids in treatment of ocular disease.

Authors:  Jeffrey H Boatright; John M Nickerson; Anisha G Moring; Machelle T Pardue
Journal:  J Ocul Biol Dis Infor       Date:  2009-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.